Axonius Unified Device Observability vs RoboShadow: Side-by-Side Comparison (2026)

Axonius Unified Device Observability: Asset visibility & risk mgmt platform for healthcare medical & IT devices. built by Axonius. Core capabilities include Medical device discovery and classification with 150+ attributes per asset, Support for medical protocols including HL7, DICOM, RTLS, and MDS2, Fleet-level risk scoring with FDA and MDS2 data integration..

RoboShadow: Automated vulnerability assessment and remediation platform. built by RoboShadow. Core capabilities include Internal Vulnerabilty Scanning, External Scanning, AI Penetration Test..

Both serve the Medical Device Security market but differ in approach, feature depth, and target audience.

Axonius Unified Device Observability differentiates with Medical device discovery and classification with 150+ attributes per asset, Support for medical protocols including HL7, DICOM, RTLS, and MDS2, Fleet-level risk scoring with FDA and MDS2 data integration. RoboShadow differentiates with Internal Vulnerabilty Scanning, External Scanning, AI Penetration Test.

Axonius Unified Device Observability is developed by Axonius. RoboShadow is developed by RoboShadow. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

Axonius Unified Device Observability integrates with NAC, Firewalls, Ticketing Systems, CMMS. RoboShadow integrates with Shodan, NMAP, Active Directory, Azure AD, Microsoft 365 and 2 more. Check integration compatibility with your existing security stack before deciding.

Axonius Unified Device Observability and RoboShadow serve similar Medical Device Security use cases. Review the feature comparison above to determine which fits your requirements.